A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Rossana IngargiolaMaria Carmen De SantisNicola Alessandro IacovelliNadia FacchinettiAnna CavalloEliana IvaldiMichela DispinzieriMarzia FranceschiniCarlotta GiandiniDomenico Attilio RomanelloSimona Di BiasoMichela SabettiLaura LocatiSalvatore AlfieriPaolo BossiMauro GuglielmoFabio MacchiLaura LozzaRiccardo ValdagniCarlo FallaiEmanuele PignoliEster OrlandiPublished in: Radiation oncology (London, England) (2020)
The study was approved by the Ethical Committee of Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (INT 52/14 - NCT02261181 ). Registered on ClinicalTrial.gov on 21st August 2017.